NREP
NEW REPRESENTATIVE AT IB RECEIVED
14/02/2025
Voltar para busca
Dado oficial do USPTO
AT THE EDGE OF IMPOSSIBLE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
AT THE EDGE OF IMPOSSIBLE
ST13
US500000079293469Classe
1, 5, 42
Pedido
79293469
Registro
6458258
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
14/02/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
19/11/2019
Data de registro
24/08/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/08/2021
Última transação
14/02/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
LINDEMYER, ANKHI
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Oxford Genetics Ltd
Representantes
John R. Schaefer Bacon & Thomas, PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals and biological preparations for use in science and industry; nucleic acids for other than medical and veterinary purposes; nucleic recombinant acidssynthetic deoxyribonucleic acids for other than medical and veterinary purposes; chemical and biological reagents for non-medical purposesreagents for use in scientific apparatus for chemical or biological analysis; chemical and biological reagents for scientific and research purposes; human or animal stem cells and parts thereof for non-medical purposes; cultures of microorganisms for non-medical and non-veterinary purposes; human or animal cells and parts thereof for scientific and research purposes; cultures of microorganisms for scientific and research purposesother than for medical or veterinary use
Classe 5
Chemical and biological reagents for medical and veterinary purposes; diagnostic and test reagents for medical and veterinary use; human or animal cells and parts thereof for medical and veterinary purposes; cultures of microorganisms for medical and veterinary purposes
Classe 42
Design services relating to the creation and alteration of chemical and biological reagentscustom design and development of chemical reagents and biochemical assays; custom design and development of chemical reagents and biochemical assaysdesign services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant virusesscientific development of recombinant viruses; design services relating to the creation and alteration of antibodiesscientific development of antibodies; design services relating to the creation and alteration of cell lineselementary cells and parts thereofscientific development of cell lineselementary cells and structural parts thereof
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/11/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/03/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/03/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/03/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/03/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
27/02/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/02/2022
FIMP
FINAL DISPOSITION PROCESSED
03/02/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/11/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
24/08/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/07/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2021
PUBO
PUBLISHED FOR OPPOSITION
08/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
05/05/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/05/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
05/05/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/05/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
28/03/2021
GNFR
FINAL REFUSAL E-MAILED
28/03/2021
CNFR
FINAL REFUSAL WRITTEN
28/03/2021
DOCK
ASSIGNED TO EXAMINER
02/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/01/2021
RFNT
REFUSAL PROCESSED BY IB
19/10/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/10/2020
RFRR
REFUSAL PROCESSED BY MPU
30/09/2020
MAFR
APPLICATION FILING RECEIPT MAILED
15/09/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/09/2020
CNRT
NON-FINAL ACTION WRITTEN
13/09/2020
DOCK
ASSIGNED TO EXAMINER
11/09/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/09/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AT THE EDGE OF IMPOSSIBLE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.